Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about ...

Kesselring started the season on injured reserve, but he’s now three games into his tenure as a Sabre, playing on a pairing ...

The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and ...